Amedeo Smart

Free Medical Literature Service

 

Amedeo

Autoimmune Disorders
  Free Subscription

Articles published in
J Immunol
    August 2026
  1. CORTEZ A, Mendyka LK, Roy A, Skydel JJ, et al
    A skin-kidney neutrophil axis links ultraviolet exposure to renal angiogenesis and tissue remodeling in healthy and lupus kidneys.
    J Immunol. 2026;215:vkag178.
    >> Share

  2. SCHARMANN SD, Faber F, Hoorens van Heyningen L, Reljic M, et al
    Nanobodies specific for Vbeta11 enable detection and noninvasive imaging of antigen-specific T cells in vivo.
    J Immunol. 2026;215:vkag237.
    >> Share

    July 2026
  3. KANNAN SK, Turner TJ, Heidarian M, Mix MR, et al
    Whole-body irradiation causes long-term impairments in the maintenance and function of naive CD4 T cells specific for self- and non-self-antigens.
    J Immunol. 2026;215:vkag174.
    >> Share

  4. KUMAR M, Wilhelm CR, Boyden AW
    Modeling pathogenic B cell function in experimental autoimmune encephalomyelitis.
    J Immunol. 2026;215:vkag163.
    >> Share

  5. PRADO DE MAIO D, Tetteh S, Ayers C, St Martin A, et al
    Lowering CD40L expression in murine lupus results in an increase in disease indicators in female but not male B6 mice.
    J Immunol. 2026;215:vkag205.
    >> Share

    May 2026
  6. PATINO-MARTINEZ E, Hajihosseini M, Hanata N, Jiang K, et al
    Longitudinal multiomic and spatial transcriptomic profiling of lupus nephritis progression in a murine model.
    J Immunol. 2026;215:vkag100.
    >> Share

  7. AKBAR I, Arokia Doss PMI, Patel PU, Surury B, et al
    Myelin antigen-specific effector CD8+ T cells induce chronic CNS autoimmunity in a CD4+ T cell-dependent manner.
    J Immunol. 2026;215:vkag107.
    >> Share

  8. ROMO-TENA J, Sengupta S, Carmona-Rivera C, Nakabo S, et al
    Preconditioning determines engraftment and therapeutic efficacy of anti-CD19 CAR-T cells in murine lupus.
    J Immunol. 2026;215:vkag112.
    >> Share

    April 2026
  9. AL-HALLAF R, Agha Z, Caturegli P, Rosenberg A, et al
    Leveraging a naturally occurring IgM autoantibody to target diabetogenic T cells: a precision medicine approach to type 1 diabetes.
    J Immunol. 2026;215:vkag056.
    >> Share

  10. HORNICK EL, Oxley K, Debreceni IL, Wieting N, et al
    Syk inhibition limits autoimmunity and abnormal B cell phenotype and function in mice with B cell-specific TRAF3 deficiency.
    J Immunol. 2026;215:vkag049.
    >> Share

  11. KHANDELWAL S, Chen J, Myoung SS, Lee GM, et al
    The influence of nuclear antigen form on complement activation by systemic lupus erythematosus antinuclear antibody immune complexes determined by a novel immunocapture assay.
    J Immunol. 2026;215:vkag088.
    >> Share

  12. SHANG XY, Zhang R, Tan LG, Wang HY, et al
    The autoantibody beta1-AA contributes to N/OFQ-exacerbated ventricular arrhythmias following acute myocardial ischemia.
    J Immunol. 2026;215:vkag072.
    >> Share

  13. ZHU Y, Choi SC, Shlomchik MJ, Morel L, et al
    GLUT1-mediated glucose flux constrains autoreactive but not foreign antigen-specific B-cell responses.
    J Immunol. 2026;215:vkag092.
    >> Share

  14. GANUGULA R, Babalola KT, Arora M, Maruvada V, et al
    Combined cyclosporine A and urolithin A therapy ameliorates murine lupus nephritis.
    J Immunol. 2026;215:vkag087.
    >> Share

    March 2026
  15. PREMACHANDRAN S, Groh AMR, Sinott A, Senthil S, et al
    Margins of control: ventricular brain borders as architects in central nervous system autoimmunity.
    J Immunol. 2026;215.
    >> Share

  16. YIN M, Hiam-Galvez KJ, Proekt I, Chan J, et al
    Immune checkpoints in a genetically engineered mouse model of spontaneous autoimmune uveitis.
    J Immunol. 2026;215:vkaf334.
    >> Share

    February 2026
  17. MIZUNO Y, Matsushita H, Fukushima Y, Kobuchi S, et al
    Endothelial semaphorin 6D controls immune responses under cold stress through regulation of sympathetic innervation.
    J Immunol. 2026;215:vkaf362.
    >> Share

  18. AMDARE N, Ali R, Manganaro A, Baker JC, et al
    Islet-derived T cells from both mice and humans recognize conserved insulin A-chain peptides presented by HLA-C*03:04.
    J Immunol. 2026;215:vkaf381.
    >> Share

  19. CHEN J, Fu L, Gong Y, Liao L, et al
    IFNgamma/JAK/STAT1/CD38 pathway in SH2D1Bhigh NK cells: Implications for inflammation in type 1 diabetes.
    J Immunol. 2026;215:vkaf347.
    >> Share

    December 2025
  20. CONWAY H, Bernard J, Ramos R, Zahran S, et al
    Altered B cell metabolic pathways characterize type 1 diabetes progression.
    J Immunol. 2025 Dec 27:vkaf330. doi: 10.1093.
    >> Share

  21. OLEINIKA K, Correia Ferreira A, Mouftakir S, Castrillon C, et al
    Dynamic control of autoreactive B cells from spontaneous germinal centers.
    J Immunol. 2025;214:3208-3217.
    >> Share

  22. ROY U, Raghavan SC
    Regulation of B-cell development and differentiation by microRNAs during immune response and their implications in immunological disorders.
    J Immunol. 2025;214:3199-3207.
    >> Share

  23. PANDEY JP
    Immunoglobulin GM (gamma marker) allotypes and their role in immune response and disease susceptibility.
    J Immunol. 2025;214:3181-3187.
    >> Share

    November 2025
  24. DIAS DA ROCHA LIMA A, De Oliveira MG, Ferrari B, C Fonseca R, et al
    Dimethyl fumarate protects from experimental autoimmune encephalomyelitis by modulating colonic immune cells.
    J Immunol. 2025 Nov 1:vkaf289. doi: 10.1093.
    >> Share

  25. YU R, Kim S, Li S, Yang W, et al
    Intronic miR-342 is a key regulator of cellular glycolysis in Foxp3+ regulatory CD4 T cells.
    J Immunol. 2025;214:2976-2986.
    >> Share

    October 2025
  26. CHURCH ME, Hernandez SI, Alvarez JI
    Neuroinflammatory canine disorders: unveiling disease mechanisms from a One Health perspective.
    J Immunol. 2025;214:2535-2542.
    >> Share

    September 2025
  27. ZIPFEL PF, Heidenreich K
    The 4 functional segments of Factor H: Role in physiological target recognition and contribution to disease.
    J Immunol. 2025;214:2150-2164.
    >> Share

  28. LIU F, Wawersik S, Tomlinson S, Thurman JM, et al
    Tissue-targeted regulators of complement for amelioration of human disease: rationale and novel therapeutic strategies.
    J Immunol. 2025;214:2138-2149.
    >> Share

    August 2025
  29. RACINE JJ, Dwyer JR, Chapman HD, Bell A, et al
    Direct-in-NOD genetic ablation of Bcl3 leads to complete type 1 diabetes protection.
    J Immunol. 2025 Aug 12:vkaf189. doi: 10.1093.
    >> Share

    July 2025
  30. OO TT, Hariharasubramanian A, Pallikonda Chakravarthy S, Singh N, et al
    Age-related decline in HMGB1-neutralizing IgM autoantibody response impairs resistance to high-fat diet in mice.
    J Immunol. 2025 Jul 29:vkaf172. doi: 10.1093.
    >> Share

  31. VDOVENKO D, Stefanska M, Wijnen WJ, Zarak-Crnkovic M, et al
    IL-23 promotes T cell trafficking in experimental autoimmune myocarditis.
    J Immunol. 2025 Jul 21:vkaf150. doi: 10.1093.
    >> Share

    June 2025
  32. JIANG K, Xu Y, Wang Y, Yin N, et al
    Deciphering the role of IL-17D, its newly identified receptor CD93, and IL-17D-CD93 axis in health and disease.
    J Immunol. 2025;214:1113-1122.
    >> Share

  33. ZHEN Y, Shao WH
    WDFY1-expressing follicular dendritic cells play a critical role in lupus development in cGVHD mouse model.
    J Immunol. 2025;214:1160-1172.
    >> Share

    May 2025
  34. CHEN N, Wu J, Sun D, Kaplan HJ, et al
    Mice deficient of G-protein coupled receptor 3 (GPR3) developed severe experimental autoimmune uveitis (EAU) through increased effector T cell activities.
    J Immunol. 2025 May 17:vkaf099. doi: 10.1093.
    >> Share

    April 2025
  35. TURICEK DP, Wan X
    Decoding autoimmunity: HLA-DQbeta and type 1 diabetes.
    J Immunol. 2025 Apr 28:vkaf070. doi: 10.1093.
    >> Share

  36. ZHENG G, Oo TT, Janjam SSS, Ellis C, et al
    An antigen-less pro-vaccine for treating autoimmunity.
    J Immunol. 2025 Apr 24:vkaf068. doi: 10.1093.
    >> Share

  37. AHN SH, Halgren K, Grzesiak G, MacRenaris KW, et al
    Autoimmune regulator deficiency causes sterile epididymitis and impacts male fertility through disruption of inorganic physiology.
    J Immunol. 2025 Apr 23:vkaf054. doi: 10.1093.
    >> Share

  38. DICILLO EB, Pisetsky DS, Svenungsson E, Diaz-Gallo LM, et al
    Characterization of autoantibody profiles in clusters of systemic lupus erythematosus using a novel autoantigen discovery technology.
    J Immunol. 2025 Apr 3:vkae025. doi: 10.1093.
    >> Share

    March 2025
  39. SUAN D, Moore J, Goodnow CC
    Can autoimmune disease be cured by deep CD19+ cell depletion?
    J Immunol. 2025 Mar 21:vkaf008. doi: 10.1093.
    >> Share

  40. HUI CW, Wu WC, Tong TK, Shiu C, et al
    Discovery of a new anti-gammac antibody in clinical development for the treatment of autoimmune diseases.
    J Immunol. 2025 Mar 12:vkae020. doi: 10.1093.
    >> Share

    January 2025
  41. HIGDON LE, Cooney LA, Serti E, Suwannasaen D, et al
    Early expansion of TIGIT+PD1+ effector memory CD4 T cells via agonistic effect of alefacept in new-onset type 1 diabetes.
    J Immunol. 2025;214:12-22.
    >> Share

    October 2024
  42. PENG W, Merlo LMF, Grabler S, Montgomery JD, et al
    IDO2 Drives Autoantibody Production and Joint Inflammation in a Preclinical Model of Arthritis by Repressing Runx1 Function in B Cells.
    J Immunol. 2024 Oct 14:ji2400445. doi: 10.4049/jimmunol.2400445.
    >> Share

  43. TAYLOR JP, Blum SI, Graffeo HC, Shang Q, et al
    The Type 1 Diabetes-Associated Single Nucleotide Polymorphism rs1990760 in IFIH1 Is Associated with Increased Basal Type I IFNs and IFN-stimulated Gene Expression.
    J Immunol. 2024 Oct 7:ji2400344. doi: 10.4049/jimmunol.2400344.
    >> Share

  44. LEBER A, Hontecillas R, Tubau-Juni N, Fitch SN, et al
    Immunometabolic Mechanisms of LANCL2 in CD4+ T Cells and Phagocytes Provide Protection from Systemic Lupus Erythematosus.
    J Immunol. 2024 Oct 4:ji2400127. doi: 10.4049/jimmunol.2400127.
    >> Share

    September 2024
  45. ZHONG B, Zhou JQ, Lyu X, Liu H, et al
    Anti-Heat Shock Protein 70 Autoantibodies from Patients with Idiopathic Pulmonary Fibrosis Epigenetically Enhance Lung Fibroblast Apoptosis Resistance and Bcl-2 Expression.
    J Immunol. 2024 Sep 9:ji2400106. doi: 10.4049/jimmunol.2400106.
    >> Share

  46. LIU JQ, Jabbari A, Lin CH, Akkanapally V, et al
    IL-27 Gene Therapy Ameliorates IPEX Syndrome Caused by Germline Mutation of Foxp3 Gene: A Major Role for Induction of IL-10.
    J Immunol. 2024;213:559-566.
    >> Share

    August 2024
  47. BLEVINS LK, Khan DMIO, Crawford RB, O'Neill C, et al
    CD9 and Aryl Hydrocarbon Receptor Are Markers of Human CD19+CD14+ Atypical B Cells and Are Dysregulated in Systemic Lupus Erythematous Disease.
    J Immunol. 2024 Aug 30:ji2400193. doi: 10.4049/jimmunol.2400193.
    >> Share

  48. SANTANA S, Papillion A, Foote JB, Bachus H, et al
    Cutting Edge: Low-dose Recombinant IL-2 Treatment Prevents Autoantibody Responses in Systemic Lupus Erythematosus via Regulatory T Cell-independent Depletion of T Follicular Helper Cells.
    J Immunol. 2024 Aug 28:ji2400264. doi: 10.4049/jimmunol.2400264.
    >> Share

  49. GREBINOSKI S, Pieklo G, Zhang Q, Visperas A, et al
    Regulatory T Cell Insufficiency in Autoimmune Diabetes Is Driven by Selective Loss of Neuropilin-1 on Intraislet Regulatory T Cells.
    J Immunol. 2024 Aug 7:ji2300216. doi: 10.4049/jimmunol.2300216.
    >> Share

  50. ZHANG J, Ji H, Liu M, Zheng M, et al
    Mitochondrial DNA Programs Lactylation of cGAS to Induce IFN Responses in Patients with Systemic Lupus Erythematosus.
    J Immunol. 2024 Aug 2:ji2300758. doi: 10.4049/jimmunol.2300758.
    >> Share

    July 2024
  51. CHIU H, Weinstein KN, Spath S, Hu A, et al
    SKI Regulates Medullary Thymic Epithelial Cell Differentiation to Control Peripheral T Cell Responses in Mice.
    J Immunol. 2024;213:52-62.
    >> Share

  52. PATINO-MARTINEZ E, Nakabo S, Jiang K, Carmona-Rivera C, et al
    The Aconitate Decarboxylase 1/Itaconate Pathway Modulates Immune Dysregulation and Associates with Cardiovascular Disease Markers and Disease Activity in Systemic Lupus Erythematosus.
    J Immunol. 2024 Jul 1:ji2400241. doi: 10.4049/jimmunol.2400241.
    >> Share

    June 2024
  53. VISWANATH V, Mistry S, Cabrera-Ghayouri S, Leang R, et al
    Sustained Alleviation of Autoimmunity by Activating alpha2B-adrenergic Receptors.
    J Immunol. 2024 Jun 28:ji2300893. doi: 10.4049/jimmunol.2300893.
    >> Share

  54. CARBONE F, Colamatteo A, La Rocca C, Lepore MT, et al
    Metabolic Plasticity of Regulatory T Cells in Health and Autoimmunity.
    J Immunol. 2024;212:1859-1866.
    >> Share

  55. VEMULAWADA C, Renavikar PS, Crawford MP, Steward-Tharp S, et al
    Disruption of IFNgamma, GZMB, PRF1, or LYST Results in Reduced Suppressive Function in Human CD8+ T Cells.
    J Immunol. 2024;212:1722-1732.
    >> Share

    May 2024
  56. WON KD, Gil Gonzalez L, Cruz-Leal Y, Pavon Oro A, et al
    Antagonism of the Platelet-Activating Factor Pathway Mitigates Inflammatory Adverse Events Driven by Anti-erythrocyte Antibody Therapy in Mice.
    J Immunol. 2024;212:1531-1539.
    >> Share

  57. DAI YD, Du W, Wang Y, Hu WY, et al
    A Targeted Deep Sequencing Method to Quantify Endogenous Retrovirus Gag Sequence Variants and Open Reading Frames Expressed in Nonobese Diabetic Mice.
    J Immunol. 2024 May 13:ji2300660. doi: 10.4049/jimmunol.2300660.
    >> Share

    April 2024
  58. TAO Q, Chen Y, Liang Q, Shi J, et al
    Puerarin Alleviates Experimental Autoimmune Thyroiditis by Regulating Macrophages.
    J Immunol. 2024 Apr 26:ji2300779. doi: 10.4049/jimmunol.2300779.
    >> Share

  59. LORANT AK, Yoshida AE, Gilbertson EA, Chu T, et al
    Integrin alphavbeta3 Limits Cytokine Production by Plasmacytoid Dendritic Cells and Restricts TLR-Driven Autoimmunity.
    J Immunol. 2024 Apr 12:ji2300290. doi: 10.4049/jimmunol.2300290.
    >> Share

  60. DE GEORGE DJ, Jhala G, Selck C, Trivedi P, et al
    Altering beta Cell Antigen Exposure to Exhausted CD8+ T Cells Prevents Autoimmune Diabetes in Mice.
    J Immunol. 2024 Apr 8:ji2300785. doi: 10.4049/jimmunol.2300785.
    >> Share

  61. FRANK C, Salapa HE, Allen KJH, Levin MC, et al
    Antibody-Mediated Depletion of Autoreactive T Lymphocytes through PD-1 Improves Disease Outcomes and Visualizes T Cell Activation in Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2024 Apr 5:ji2300751. doi: 10.4049/jimmunol.2300751.
    >> Share

  62. WU J, Han K, Sack MN
    Targeting NAD+ Metabolism to Modulate Autoimmunity and Inflammation.
    J Immunol. 2024;212:1043-1050.
    >> Share

    March 2024
  63. COSTANZO A, Clarke D, Holt M, Sharma S, et al
    Repositioning the Early Pathology of Type 1 Diabetes to the Extraislet Vasculature.
    J Immunol. 2024 Mar 1:ji2300769. doi: 10.4049/jimmunol.2300769.
    >> Share

    February 2024
  64. KAGOHASHI K, Sasaki Y, Ozawa K, Tsuchiya T, et al
    Role of Signal-Transducing Adaptor Protein-1 for T Cell Activation and Pathogenesis of Autoimmune Demyelination and Airway Inflammation.
    J Immunol. 2024 Feb 5:ji2300202. doi: 10.4049/jimmunol.2300202.
    >> Share

  65. DUAN S, Li Q, Wang F, Kuang W, et al
    Single-Cell Transcriptomes and Immune Repertoires Reveal the Cell State and Molecular Changes in Pemphigus Vulgaris.
    J Immunol. 2024;212:375-388.
    >> Share

    January 2024
  66. DAR AA, Ortega Y, Aktas S, Wu K, et al
    CRL4b Inhibition Ameliorates Experimental Autoimmune Encephalomyelitis Progression.
    J Immunol. 2024 Jan 24:ji2300754. doi: 10.4049/jimmunol.2300754.
    >> Share

  67. YANDAMURI SS, Filipek B, Lele N, Cohen I, et al
    A Noncanonical CD56dimCD16dim/- NK Cell Subset Indicative of Prior Cytotoxic Activity Is Elevated in Patients with Autoantibody-Mediated Neurologic Diseases.
    J Immunol. 2024 Jan 22:ji2300015. doi: 10.4049/jimmunol.2300015.
    >> Share

  68. TOMALA J, Cao SD, Spangler JB
    Engineering Anticytokine Antibodies for Immune Modulation.
    J Immunol. 2024;212:225-234.
    >> Share

  69. HAN K, Xu J, Xie F, Crowther J, et al
    Engineering Strategies to Modulate the Gut Microbiome and Immune System.
    J Immunol. 2024;212:208-215.
    >> Share

  70. KLUG N, Burke J, Scott E
    Rational Engineering of Islet Tolerance via Biomaterial-Mediated Immune Modulation.
    J Immunol. 2024;212:216-224.
    >> Share

    December 2023
  71. FLYNN AL, Gans J, Escobedo J, Zhu C, et al
    RGS1 Modulates Autophagic and Metabolic Programs and Is a Critical Mediator of Human Regulatory T Cell Function.
    J Immunol. 2023;211:1656-1668.
    >> Share

    November 2023
  72. SONI C, Makita S, Eichinger A, Serpas L, et al
    Cutting Edge: TLR2 Signaling in B Cells Promotes Autoreactivity to DNA via IL-6 Secretion.
    J Immunol. 2023;211:1475-1480.
    >> Share

  73. LU Y, Chiang J, Zhang R, Roche PA, et al
    TRAF6 and TRAF2/3 Binding Motifs in CD40 Differentially Regulate B Cell Function in T-Dependent Antibody Responses and Dendritic Cell Function in Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2023 Nov 3:ji2300607. doi: 10.4049/jimmunol.2300607.
    >> Share

  74. MONSON N, Smith C, Greenberg H, Plumb P, et al
    VH2+ Antigen-Experienced B Cells in the Cerebrospinal Fluid Are Expanded and Enriched in Pediatric Anti-NMDA Receptor Encephalitis.
    J Immunol. 2023;211:1332-1339.
    >> Share

  75. AKBAR I, Tang R, Baillargeon J, Roy AP, et al
    Cutting Edge: Serpine1 Negatively Regulates Th1 Cell Responses in Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2023 Nov 1:ji2300526. doi: 10.4049/jimmunol.2300526.
    >> Share

  76. PELLERIN A, Tan Y, Lu S, Bonegio RG, et al
    Genetic Reduction of IRF5 Expression after Disease Initiation Reduces Disease in a Mouse Lupus Model by Impacting Systemic and End-Organ Pathogenic Pathways.
    J Immunol. 2023;211:1308-1319.
    >> Share

    October 2023
  77. RACINE JJ, Misherghi A, Dwyer JR, Maser R, et al
    HLA-DQ8 Supports Development of Insulitis Mediated by Insulin-Reactive Human TCR-Transgenic T Cells in Nonobese Diabetic Mice.
    J Immunol. 2023 Oct 25:ji2300303. doi: 10.4049/jimmunol.2300303.
    >> Share

  78. SOUKOU-WARGALLA S, Kilian C, Velasquez LN, Machicote A, et al
    Tr1 Cells Emerge and Suppress Effector Th17 Cells in Glomerulonephritis.
    J Immunol. 2023 Oct 18:ji2300305. doi: 10.4049/jimmunol.2300305.
    >> Share

  79. JORDAN TJM, Chen J, Li N, Burette S, et al
    The Eotaxin-1/CCR3 Axis and Matrix Metalloproteinase-9 Are Critical in Anti-NC16A IgE-Induced Bullous Pemphigoid.
    J Immunol. 2023;211:1216-1223.
    >> Share

  80. GILLES A, Hu L, Virdis F, Sant'Angelo DB, et al
    The MHC Class II Antigen-Processing and Presentation Pathway Is Dysregulated in Type 1 Diabetes.
    J Immunol. 2023 Oct 9:ji2300213. doi: 10.4049/jimmunol.2300213.
    >> Share

  81. MOK MY, Luo CY, Huang FP, Kong WY, et al
    IL-33 Orchestrated the Interaction and Immunoregulatory Functions of Alternatively Activated Macrophages and Regulatory T Cells In Vitro.
    J Immunol. 2023;211:1134-1143.
    >> Share

    September 2023
  82. NEW JS, Dizon BLP, King RG, Greenspan NS, et al
    B-1 B Cell-Derived Natural Antibodies against N-Acetyl-d-Glucosamine Suppress Autoimmune Diabetes Pathogenesis.
    J Immunol. 2023 Sep 25:ji2300264. doi: 10.4049/jimmunol.2300264.
    >> Share

  83. MORIN F, Singh N, Mdzomba JB, Dumas A, et al
    Correction: Conditional Deletions of Hdc Confirm Roles of Histamine in Anaphylaxis and Circadian Activity but Not in Autoimmune Encephalomyelitis.
    J Immunol. 2023 Sep 11:ji2300549. doi: 10.4049/jimmunol.2300549.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016